Annual EBIT
-$47.35 M
+$1.27 M+2.60%
31 December 2023
Summary:
Viracta Therapeutics annual earnings before interest & taxes is currently -$47.35 million, with the most recent change of +$1.27 million (+2.60%) on 31 December 2023. During the last 3 years, it has risen by +$66.92 million (+58.56%). VIRX annual EBIT is now -151.87% below its all-time high of -$18.77 million.VIRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$9.87 M
-$741.00 K-8.11%
30 September 2024
Summary:
Viracta Therapeutics quarterly earnings before interest & taxes is currently -$9.87 million, with the most recent change of -$741.00 thousand (-8.11%) on 30 September 2024. Over the past year, it has increased by +$2.94 million (+22.96%). VIRX quarterly EBIT is now -146.05% below its all-time high of -$4.01 million, reached on 30 September 2020.VIRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$40.11 M
+$1.77 M+4.23%
30 September 2024
Summary:
Viracta Therapeutics TTM earnings before interest & taxes is currently -$40.11 million, with the most recent change of +$1.77 million (+4.23%) on 30 September 2024. Over the past year, it has increased by +$7.25 million (+15.31%). VIRX TTM EBIT is now -807.99% below its all-time high of -$4.42 million, reached on 31 March 2020.VIRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +23.0% | +15.3% |
| 3 y3 years | +58.6% | +12.7% | +64.9% |
| 5 y5 years | - | - | - |
VIRX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -151.9% | +58.6% | -19.2% | +43.9% | at high | +64.9% |
| 5 y | 5 years | -151.9% | +58.6% | -146.1% | +87.5% | -808.0% | +64.9% |
| alltime | all time | -151.9% | +58.6% | -146.1% | +87.5% | -808.0% | +64.9% |
Viracta Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.87 M(+8.1%) | -$40.11 M(-4.2%) |
| June 2024 | - | -$9.13 M(+10.3%) | -$41.88 M(-5.5%) |
| Mar 2024 | - | -$8.28 M(-35.4%) | -$44.31 M(-6.4%) |
| Dec 2023 | -$47.35 M(-2.6%) | -$12.82 M(+10.0%) | -$47.35 M(+6.0%) |
| Sept 2023 | - | -$11.65 M(+0.7%) | -$44.68 M(-11.8%) |
| June 2023 | - | -$11.56 M(+2.1%) | -$50.63 M(+2.2%) |
| Mar 2023 | - | -$11.33 M(+11.7%) | -$49.53 M(+1.9%) |
| Dec 2022 | -$48.62 M | -$10.14 M(-42.4%) | -$48.62 M(-2.3%) |
| Sept 2022 | - | -$17.60 M(+68.4%) | -$49.79 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$10.46 M(+0.3%) | -$46.97 M(+3.1%) |
| Mar 2022 | - | -$10.42 M(-7.8%) | -$45.57 M(-60.1%) |
| Dec 2021 | -$114.27 M(+507.8%) | -$11.31 M(-23.5%) | -$114.27 M(+4.7%) |
| Sept 2021 | - | -$14.79 M(+63.5%) | -$109.10 M(+11.0%) |
| June 2021 | - | -$9.05 M(-88.6%) | -$98.32 M(+5.1%) |
| Mar 2021 | - | -$79.13 M(+1189.7%) | -$93.51 M(+397.4%) |
| Dec 2020 | -$18.80 M | -$6.13 M(+52.9%) | -$18.80 M(+48.4%) |
| Sept 2020 | - | -$4.01 M(-5.3%) | -$12.67 M(+46.4%) |
| June 2020 | - | -$4.24 M(-4.1%) | -$8.65 M(+95.9%) |
| Mar 2020 | - | -$4.42 M | -$4.42 M |
FAQ
- What is Viracta Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly EBIT year-on-year change?
- What is Viracta Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Viracta Therapeutics?
- What is Viracta Therapeutics TTM EBIT year-on-year change?
What is Viracta Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VIRX is -$47.35 M
What is the all time high annual EBIT for Viracta Therapeutics?
Viracta Therapeutics all-time high annual earnings before interest & taxes is -$18.77 M
What is Viracta Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VIRX is -$9.87 M
What is the all time high quarterly EBIT for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly earnings before interest & taxes is -$4.01 M
What is Viracta Therapeutics quarterly EBIT year-on-year change?
Over the past year, VIRX quarterly earnings before interest & taxes has changed by +$2.94 M (+22.96%)
What is Viracta Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VIRX is -$40.11 M
What is the all time high TTM EBIT for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM earnings before interest & taxes is -$4.42 M
What is Viracta Therapeutics TTM EBIT year-on-year change?
Over the past year, VIRX TTM earnings before interest & taxes has changed by +$7.25 M (+15.31%)